A new report on Crestor is raising safety concerns AGAIN

July 2005

A new report on Crestor is raising safety concerns AGAIN.

This analysis suggests a trend towards more cases of severe myopathy and a higher rate of proteinuria with Crestor.

The FDA looked at this data previously...and decided to leave Crestor on the market for now. They say the incidence of side effects with Crestor is similar to that of the other statins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Researchers are now taking omega-3 fatty acids more seriously
Infectious Diseases HIGHER doses of Bactrim or Septra for MRSA skin infections
Infectious Diseases a new IV antibiotic called Tygacil
Infectious Diseases Zostavax, a new vaccine for shingles
Kidney Disease best way to measure kidney function
Diabetes PREVENTING type 2 diabetes
Diabetes Accidental changes in glucose meter settings can cause some patients to misinterpret their blood glucose readings
Dermatology poison ivy/poison oak
Dermatology recent headlines that suggest sunscreens cause cancer
SSRIs seem to increase the risk of GI bleeding
Heart Disease A new report on Crestor is raising safety concerns AGAIN
Heart Disease new form of Viagra called Revatio
Supplements How much oral vitamin B12 is needed to treat B12 deficiency
Should patients at risk for anaphylaxis avoid beta-blockers
pharmacogenomics to personalize drug therapy based on a person's genes

A new report on Crestor is raising safety concerns AGAIN

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents